Kits Eyecare Ltd (KITS)

Currency in CAD
14.25
+0.55(+4.01%)
Closed·
KITS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
13.8314.29
52 wk Range
10.6122.56
Key Statistics
Prev. Close
13.7
Open
13.91
Day's Range
13.83-14.29
52 wk Range
10.61-22.56
Volume
82.67K
Average Volume (3m)
120.64K
1-Year Change
-11.9283%
Book Value / Share
2.14
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
KITS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
22.93
Upside
+60.90%
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week

Kits Eyecare Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

6 Buy
1 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 22.93
(+60.90% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Canaccord
Buy26.50+85.96%22.00Maintain06/08/2026
Roth/MKM
Buy26.00+82.46%27.00Maintain28/04/2026
Desjardins
Buy25.00+75.44%23.00Maintain05/03/2026
Desjardins
Buy23.00+61.40%-Maintain27/10/2025

Kits Eyecare Ltd Earnings Call Summary for Q2/2026

  • Kits Eyecare Q2 revenue rose 17.8% YoY to CAD 58.4M; posted CAD 1.5M net income vs. year-ago loss; shares up 6.99% to $14.69.
  • Adjusted EBITDA reached CAD 2.9M (5.0% margin); gross margin expanded 160 bps to 37.9% driven by premium product mix and efficiency.
  • Generated record operating cash flow of CAD 7.8M; ended quarter with CAD 27.4M cash, zero debt, and CAD 42.4M accessible liquidity.
  • Q3 guidance: revenue CAD 62-64M with adjusted EBITDA margin of 4-6%; investing in customer acquisition and glasses category expansion.
  • Glasses revenue surged 54% YoY to CAD 11.1M; expanded insurance partnerships including Manulife integration; planning more flagship stores.
Last Updated: 06/08/2026, 12:22 am
Read Full Transcript

Earnings

Latest Release
05/08/2026
EPS / Forecast
0.06 / 0.04
Revenue / Forecast
58.43M / 58.22M
EPS Revisions
Last 90 days

KITS Income Statement

Compare KITS to Peers and Sector

Metrics to compare
KITS
Peers
Sector
Relationship
P/E Ratio
86.0x21.1x10.4x
PEG Ratio
1.870.460.02
Price/Book
6.7x2.0x1.4x
Price / LTM Sales
2.2x1.1x0.9x
Upside (Analyst Target)
61.4%29.6%26.1%
Fair Value Upside
Unlock16.7%11.5%Unlock

Kits Eyecare Ltd. operates a digital eyecare platform in the United States and Canada. It offers progressive, polarized, and contact lenses, eyeglasses, and frames under the KITS brand, as well as distributes eyewear products of various brands. The company operates a network of optical e-commerce websites, including KITS.com, KITS.ca, OptiContacts.com, and ContactsExpress.ca. Kits Eyecare Ltd. was founded in 2002 and is headquartered in Vancouver, Canada.

Employees
176
Market
Canada

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
3.12M9.19%44.50M
Other Institutional Investors
12.12M35.65%172.69M
Public Companies & Retail Investors
18.75M55.17%267.25M
Total
34M100.00%484.44M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Ld Group Holdings Limited30.88%10,498,089149,598
Hardy Family Foundation4.77%1,620,20423,088

People Also Watch

76.66
SJ
+2.73%
18.330
CEU
+11.50%
7.890
VHI
+12.07%
30.460
VNP
+2.80%

FAQ

What Is the Kits Eyecare (KITS) Stock Price Today?

The Kits Eyecare stock price today is 14.25 CAD.

What Stock Exchange Does Kits Eyecare Trade On?

Kits Eyecare is listed and trades on the Toronto Stock Exchange.

What Is the Stock Symbol for Kits Eyecare?

The stock symbol for Kits Eyecare is "KITS."

What Is the Kits Eyecare Market Cap?

As of today, Kits Eyecare market cap is 465.74M CAD.

What Is Kits Eyecare's Earnings Per Share (TTM)?

The Kits Eyecare EPS (TTM) is 0.16.

When Is the Next Kits Eyecare Earnings Date?

Kits Eyecare will release its next earnings report on 11/11/2026.

From a Technical Analysis Perspective, Is KITS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Kits Eyecare Stock Split?

Kits Eyecare has split 0 times.

How Many Employees Does Kits Eyecare Have?

Kits Eyecare has 176 employees.

What is the current trading status of Kits Eyecare (KITS)?

As of 08/08/2026, Kits Eyecare (KITS) is trading at a price of 14.25 CAD, with a previous close of 13.70 CAD. The stock has fluctuated within a day range of 13.83 CAD to 14.29 CAD, while its 52-week range spans from 10.61 CAD to 22.56 CAD.

What Is Kits Eyecare (KITS) Price Target According to Analysts?

The average 12-month price target for Kits Eyecare is 22.93 CAD, with a high estimate of 26.5 CAD and a low estimate of 19 CAD. 6 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +60.90% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.